These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19197595)

  • 21. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Subjective Quality of Life in opiate-dependent patients before admission after six months and one-year participation in methadone program].
    Habrat B; Chmielewska K; Baran-Furga H; Keszycka B; Taracha E
    Przegl Lek; 2002; 59(4-5):351-4. PubMed ID: 12184005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chart review comparing paregoric to methadone in the treatment of neonatal opioid withdrawal.
    Wunsch MJ
    J Addict Dis; 2006; 25(3):27-33. PubMed ID: 16956866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methadone detoxification: effects of methadone dose versus time in treatment.
    McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1984 Mar; 49():269-74. PubMed ID: 6434971
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Opiate addiction as a chronic brain disease: new concept of an old problem, and re-evaluation of methadone treatment].
    Bleich A; Adelson M
    Harefuah; 2000 Mar; 138(6):454-7. PubMed ID: 10883159
    [No Abstract]   [Full Text] [Related]  

  • 30. [Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction].
    Thirion X; Barrau K; Micallef J; Haramburu F; Lowenstein W; Sanmarco JL
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A10-7. PubMed ID: 10855372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of opiate-dependent adolescents in the Vaud canton. Reflections on the indication for treatment with methadone].
    Savoy J; Laget J; Charpentier P; Sanchez-Mazas P; Besson J; Halfon O
    Rev Med Suisse Romande; 1999 Nov; 119(11):943-50. PubMed ID: 10628219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A national study of the retention of Irish opiate users in methadone substitution treatment.
    Mullen L; Barry J; Long J; Keenan E; Mulholland D; Grogan L; Delargy I
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):551-8. PubMed ID: 22747484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methadone dosage and retention: an examination of the 60 mg/day threshold.
    Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
    J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001.
    Strike CJ; Urbanoski K; Fischer B; Marsh DC; Millson M
    J Addict Dis; 2005; 24(1):39-51. PubMed ID: 15774409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of pain on stroop performance in patients with opiate dependence in sustained remission.
    Aniskin DB; Fink E; Prosser J; Cohen LJ; Boda N; Steinfeld M; Galynker II
    J Addict Med; 2011 Mar; 5(1):50-6. PubMed ID: 21769047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating primary care and methadone maintenance treatment: implementation issues.
    Herman M; Gourevitch MN
    J Addict Dis; 1997; 16(1):91-102. PubMed ID: 9046446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian.
    Peters AD; Reid MM
    Drug Alcohol Depend; 1998 Mar; 50(1):47-55. PubMed ID: 9589272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.